Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08
March 20, 2025 16:30 ET | Source: Emergent BioSolutions GAITHERSBURG, Md., March…
Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025
NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth:…
Diality Announces First Patient Treated With Moda-flx Hemodialysis System
Patient-inspired technology delivers lifesaving dialysis therapyIRVINE, Calif.--(BUSINESS WIRE)--#dialysis--Diality, a medical device company…
Continuous Biomarker Monitoring Pioneer Proton Intelligence Inc Announces a $6.95 Million Seed Raise to Initiate Human Trials for Potassium Monitoring in Patients With Kidney Disease
VANCOUVER, British Columbia & MELBOURNE, Australia--(BUSINESS WIRE)--Proton Intelligence Inc., developing the first-ever…
Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting
NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext…